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Apelin is a vasoactive peptide identified as the endogenous
ligand of an orphan G protein-coupled receptor called APJ.
Apelin and its receptor have been found in the brain and the
cardiovascular system. Here we show that the apelin receptor
mRNA is highly expressed in the glomeruli while its level of
expression is lower in all nephron segments including
collecting ducts that express vasopressin V2 receptors.
Intravenous injection of apelin 17 into lactating rats induced
a significant diuresis. Apelin receptor mRNA was also found
in endothelial and vascular smooth muscle cells of
glomerular arterioles. Apelin administration caused
vasorelaxation of angiotensin II-preconstricted efferent and
afferent arterioles as shown by an increase in their diameter.
Activation of endothelial apelin receptors caused release of
nitric oxide which inhibited angiotensin II-induced rise in
intracellular calcium. In addition, it appears that apelin had
a direct receptor-mediated vasoconstrictive effect on
vascular smooth muscle. These results show that apelin
has complex effects on the pre- and post glomerular
microvasculature regulating renal hemodynamics. Its role
on tubular function (if any) remains to be determined.
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Apelin is a vasoactive peptide isolated from bovine
stomach extracts.1 It is identified as the endogenous ligand
of the human orphan G-protein-coupled receptor, the APJ
receptor.2 Apelin is a 36 amino-acid peptide generated from a
77 amino-acid precursor, proapelin for which cDNAs have
been cloned from humans, cattle, rats, and mice.1,3,4 A
sequence of 23 amino acids present in the C-terminal region
(from Trp55 to Phe77) is fully conserved in all species studied,
including the C-terminal 17 (Lys-Phe-Arg-Arg-Gln-Arg-Pro-
Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe, apelin 17) and 13
(Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe, ape-
lin 13) amino-acid sequences. These molecular forms of apelin
and the pyroglutamyl form of apelin 13 were identified in vivo
in various tissues and plasma.5–8 The occurrence of two
internal dibasic motifs (Arg59–Arg60, Arg63–Arg64) within
the proapelin sequences suggests that apelin 17 and the
pyroglutamyl form of apelin 13 may be processed by
prohormone convertases. Apelin 36, apelin 17, and the
pyroglutamyl form of apelin 13 exhibit a high affinity for the
apelin receptor (APJ), strongly inhibit the forskolin-induced
cAMP production in Chinese hamster ovary cells expressing
either the human or rat apelin receptor.3,9,10 These peptides
also induce internalization of the rat and human apelin
receptor,10–12 apelin 17 being more potent than the pyro-
glutamyl form of apelin 13 or apelin 12.13 In addition, the
pyroglutamyl form of apelin 13 activates ERKs via a pertussis
toxin sensitive G protein in Chinese hamster ovary cells
expressing the murine apelin receptor involving a PKC
isoform in a Ras-independent pathway.14 Apelin 36, apelin
17, and the pyroglutamyl form of apelin 13 are able to induce
a sharp rise in intracellular calcium concentrations ([Ca2þ ]i)
in human neurons in which apelin receptor mRNA is
expressed at a high level.15
Both apelin and apelin mRNA expression are widely
distributed in the brain. They are particularly highly expres-
sed in the supraoptic and paraventricular hypothalamic
nuclei,16 where they are colocalized with vasopressin (AVP)
in a subset of magnocellular neurons.7,17,18 In lactating rats,
characterized by increases in both synthesis and release of
AVP,19 central injection of apelin inhibits the phasic electrical
activity of AVP neurons, reduces plasma AVP levels, and
increases aqueous diuresis.7 Moreover, water deprivation that
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increases systemic AVP release and causes depletion of hypo-
thalamic AVP stores, decreased plasma apelin concentrations
and induced hypothalamic accumulation of the peptide,7,18
indicating that AVP and apelin are conversely regulated to
facilitate systemic AVP release and thus to prevent additional
water loss at the kidney level. Taken together, these data
highlight the crucial role played by central apelin in the
maintenance of body fluid homeostasis by counteracting
AVP actions. The effect of apelin on water diuresis could
involve not only a central effect but also a peripheral and/or
intrarenal hemodynamic effect via binding to intrarenal
receptors, since apelin receptor mRNA expression was found
in the rat kidney5,20 and apelin immunoreactivity was
detected in the human collecting tubules.21 In addition,
apelin and its receptor are present in other organs and
abundantly expressed in vessels.22,23 The injection of apelin
into the bloodstream decreases arterial blood pressure4,10,13,24
and in our hands, apelin 17 was shown to be the most
efficient hypotensive apelin fragment compared to the
pyroglutamyl form of apelin 13 or apelin 10.13 This effect
occurs via a mechanism dependent on nitric oxide (NO)
production.24 Moreover, APJ knockout mice display an
enhanced vasopressor response to systemic angiotensin II
(AngII), suggesting a counter-regulatory action of apelin on
AngII.25 In addition, apelin modulates the abnormal aortic
vascular tone in response to AngII, via endothelial NOS
phosphorylation pathway in diabetic mice, providing further
support for a role for apelin in vascular function.26 This led
us to hypothetize that apelin could modulate actions of AngII
in the renal microvasculature. Indeed, it is well established in
glomerular arterioles that the vasoconstriction induced by
AngII can be rapidly reversed by vasorelaxing factors such as
bradykinin (BK)27 or NO that ranks among the most
effective vasodilatators in the kidney.28
Thus, the present work was undertaken (1) to study the
distribution of apelin receptor mRNA expression in the four
renal zones, all along the rat nephron segments as well as in
glomerular arterioles, (2) to determine if systemic injection
of apelin 17 induced diuresis similarly to central injection,
and (3) to examine in rat juxtamedullary afferent (AA) and
muscular efferent (EA) arterioles the vasoactive effects of
apelin 17 on contractile and intracellular calcium responses
to AngII.
RESULTS
Distribution of apelin receptor mRNA expression in the rat
kidney
Apelin receptor mRNA was quantified in renal zones and
along the nephron by real-time reverse transcription-PCR.
Apelin receptor mRNA expression was the highest in the
inner stripe (IS), intermediate in the outer stripe (OS) and in
the inner medulla (IM) and, lowest in the cortex (Figure 1).
Expression of apelin receptor mRNA was very high in
glomerulus (Glom) and more moderate in the nephron
segments: proximal convoluted tubule (PCT), proximal
straight tubule of the cortex (CPST), thick ascending limb
from the outer medulla (MTAL), thick ascending limb from
the cortex (CTAL), collecting duct from the cortex (CCD),
collecting duct from the outer medulla (OMCD), and
collecting duct from the inner medulla (IMCD) (Figure 2).
Furthermore, the presence of apelin receptor mRNA
expression in glomerular arterioles was investigated by
in situ hybridization experiments using radiolabeled ribo-
probes on kidney sections. A specific labeling for apelin receptor
mRNA was observed in the vascular wall of arterioles, both
in endothelial (VEC) and vascular smooth muscle (VSMC)
cells as shown in Figure 3a. However, it was not possible to
distinguish the AA from the EA. Only minimal hybridization
signal was visible with the sense probe (Figure 3b).
Effects of apelin 17 on diuresis rate in anaesthetized virgin
and lactating female rats
For these experiments, we have used virgin female rats and
lactating female rats characterized by an increase in both
synthesis and release of AVP, to preserve hydric content of
organism for a maximal milk production.19 Diuresis rate
measured during the experimental saline period was
significantly higher in virgin than in lactating female rats:
3.07±0.44 (n¼ 7) vs 1.62±0.20 ml/min per 100 g body
weight (BW) (n¼ 7), respectively, Po0.01. In lactating rats,
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Figure 1 | Expression of relative apelin receptor mRNA in the
four renal zones. Each bar represents the mean data±s.e.m.,
n¼ 5 rats. aStatistically different from cortex, 0.0254P40.01
(ANOVA).
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Figure 2 | Expression of relative apelin receptor mRNA along
the nephron. Results were expressed as the relative value from
2 mm tubular length in percentage of the value from two Glom
microdissected in the same run. Each bar represents the mean
data±s.e.m. of 4–5 experiments.
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diuresis values measured during basal and experimental
saline periods were not significantly different (1.43±0.37
(n¼ 7) vs 1.62±0.20 ml/min per 100 g BW (n¼ 7), respec-
tively). Intravenous bolus injection of increasing doses of
apelin 17 (0.48–3.80 nmol apelin per animal) induced
significant increases in diuresis rate (from 55 to 104%,
respectively) as compared to the basal saline period
(Figure 4). In contrast, intravenous bolus injection of
0.95 nmol per animal of apelin 17 in virgin female rats (an
intermediate dose) induced a slight (39%) but not significant
increase in diuresis rate as compared to the experimental
saline period (4.26±1.05, n¼ 5 vs 3.07±0.44 ml/min per
100 g BW, n¼ 7, respectively, P¼ 0.14).
Vasoactive role of apelin in juxtamedullary glomerular
arterioles
Considering (i) the previously described vasoactive effects of
apelin, (ii) the high levels of apelin receptor mRNA observed
in the present study in the IS, and (iii) the morphological
properties of arterioles in the inner cortex that give rise to
vasa recta, the vasoreactivity of juxtamedullary AA and EA to
apelin 17 was investigated.
Since it is generally accepted that the vasoconstrictor
responses to AngII resulted from an increase in [Ca2þ ]i,
29
whereas VSMC relaxation is thought to be mainly due to a
decrease in [Ca2þ ]i,
30 we evaluated the effects of apelin 17 in
arterioles on the AngII-induced decrease in arteriolar
diameter and on the plateau phase of the [Ca2þ ]i response
to AngII.
Effects of apelin on the AngII-induced decrease in diameter of
juxtamedullary AA. To evaluate the effects of apelin on the
vascular reactivity of glomerular arterioles, diameters of AA
were measured (1) in basal conditions, (2) after adding
AngII, and (3) in the presence of AngII and apelin. Results
showed that 109 M AngII significantly reduced AA diameter
compared with values measured under baseline conditions
(18.65±0.53 vs 21.40±0.68 mm, n¼ 8, Po0.01, respec-
tively). Addition of 5 107 M apelin 17 to preconstricted
AA by 109 M AngII increased the AA diameter from
18.65±0.53 to 21.77±0.69 mm (n¼ 8, Po0.01). These
results indicated clearly that apelin 17 induced a vasodilata-
tion of AA previously preconstricted by AngII (Figure 5).
Effects of apelin 17 on the AngII-induced [Ca2þ ]i increase
in juxtamedullary AA. Figure 6a shows that 109 M AngII
induced an increase in [Ca2þ ]i followed by a plateau phase
(71±9 nM, n¼ 14) in AA and that application of 5 107 M
apelin 17 on this plateau caused a rapid drop in [Ca2þ ]i of
30±5 nM, Po0.004. This drop represented 43±5% of the
[Ca2þ ]i response induced by AngII. An application of 10
8
M
BK on the same arteriole induced a [Ca2þ ]i drop (62±6%,
n¼ 10) on the [Ca2þ ]i response induced by a second
application of AngII (as previously observed by Marchetti
et al.27 in muscular EA). The fall in [Ca2þ ]i induced by
apelin 17 was transient and lasted 1.0±0.1 min. This apelin
a b
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Figure 3 | Detection by in situ hybridization of apelin receptor
mRNA expression in glomerular arteriole. (a) Hybridization
signal was observed in VEC (arrow) and in the VSMC (arrowheads)
of arteriole (Art). A tangential section parallel to the axis of the
arteriole showed labeling where the section cut only the
endothelial cells (Figure 3a). (b) A nearly adjacent section
hybridization with the sense probe showed no labeling but a faint
background. Scale bar: 20mm.
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Figure 4 | Effects of increasing doses of apelin 17 on diuresis
rate in lactating female rats. Diuresis rate was measured in
lactating female rats during two periods of 120 min. Basal control
period (hatched column) corresponds to intravenous injection of
saline. Experimental period (closed column) corresponds to
intravenous injection of increasing doses of apelin 17: 0.48, 1.90,
and 3.80 nmol per animal. Each column represents the mean
data±s.e.m. expressed in ml/min per100 g BW. *Po0.05 and
**Po0.001 when compared to basal control period.
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Figure 5 | Effect of apelin 17 on the juxtamedullary afferent
arteriole contractile response to AngII. Arteriolar diameters
were measured in the basal conditions, then 1 min after adding
109 M AngII and 1 min after addition of 5 107 M apelin 17 on
vasoconstricted arterioles (n¼ 8); **Po0.01.
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effect was half that elicited by BK (1.96±0.28 min, Po0.01).
Figure 6b illustrates three successive [Ca2þ ]i drops elicited
by two applications of 5 107 M apelin 17 followed by one
of 108 M BK on [Ca2þ ]i responses induced by 10
9
M AngII.
These experiments showed that it is possible to repeat two
or three times on the same arteriole the inhibitory effect of
apelin 17 or BK on AngII-induced increase in [Ca2þ ]i
(Figure 6a and b), indicating the absence of desensitization
phenomenon. To determine whether the [Ca2þ ]i drop
induced by apelin 17 was mediated by the release of NO,
AA were superfused in the presence of 2 105 M L-NAME
before the addition of 109 M AngII. Figure 6c and d shows
that L-NAME inhibited the [Ca2þ ]i drop induced by apelin
17. Besides preincubation in the presence of L-NAME did
not significantly affect either the basal [Ca2þ ]i level or the
amplitude of the [Ca2þ ]i responses induced by AngII
(79±17 nM, n¼ 6) as compared with controls.
Effects of apelin 17 on the AngII-induced [Ca2þ ]i increase in
juxtamedullary muscular EA. As observed in AA, application
of 5 107 M apelin 17 in EA caused a rapid drop on the
109 M AngII-induced [Ca2þ ]i response (70±9 nM, n¼ 10)
with a similar amplitude (27±5 nM, Po0.001) (Figure 7a).
This decrease represented 44±7% of the [Ca2þ ]i response
induced by AngII. As expected, 108 M BK induced a decrease
(71±12%, n¼ 6) on the second [Ca2þ ]i response to AngII.
Similarly to AA, the duration of the vasodilator effect of
apelin 17 was transient and twice shorter than that induced
by BK (0.91±0.14 vs 2.30±0.40 min, respectively, Po0.01).
Figure 7b illustrates an experiment performed with
5 107 M apelin 17 applied on two successive responses
to 109 M AngII in the absence or presence of 2 105 M
L-NAME. On the second response elicited by AngII, we obser-
ved that L-NAME strongly inhibited the apelin 17-induced
[Ca2þ ]i drop by 72%. Data obtained were summarized in
Figure 7c.
Effect of de-endothelialization on the apelin-induced [Ca2þ ]i
drop in juxtamedullary AA. To localize in arterioles the apelin
receptors responsible for the [Ca2þ ]i decrease, the effects of
apelin were investigated in endothelium-denuded AA. In the
absence of endothelium, the [Ca2þ ]i response to 10
9
M
AngII (Figure 8b) was not significantly different from that
found on AA with functional endothelium (Figure 8a) in a
same pool of experiment (37±7, n¼ 6 vs 43±3 nM, n¼ 3,
respectively). On endothelium-denuded AA, 5 107 M
apelin failed to reduce the [Ca2þ ]i response to AngII (Figure
8b and c), indicating that the apelin receptors responsible for
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Figure 6 | Effects of apelin 17 on the [Ca2þ ]i responses to AngII in juxtamedullary afferent arterioles. (a) A representative [Ca
2þ ]i
recording illustrating the [Ca2þ ]i drops observed when 5 107 M apelin 17 was added during the plateau phase of 109 M AngII-induced
[Ca2þ ]i increase and when 10
8
M BK was added during the plateau phase of a second 109 M AngII-induced [Ca2þ ]i response is shown.
(b) The time course of two successive applications of 5 107 M apelin 17 followed by one application of 108 M BK on the plateau phase
of three different 109 M AngII-induced [Ca2þ ]i responses is illustrated. (c) A representative recording illustrating the inhibition of the
[Ca2þ ]i drop induced by 5 107 M apelin 17 on the plateau phase elicited by 109 M AngII when 2 105 M L-NAME were superfused
10 min before and during the AngII-induced [Ca2þ ]i response is shown. (d) Quantification of [Ca
2þ ]i drop induced by apelin 17 in the
absence or presence of L-NAME is shown. Each column represents the mean data±s.e.m. expressed in % of [Ca2þ ]i drop induced by
apelin 17 in the presence (hatched column, n¼ 14) or in the absence of L-NAME (closed column, n¼ 6); **Po0.0001.
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this decrease in intact arterioles were located in the endo-
thelium. The absence of endothelium was confirmed by the
non significant [Ca2þ ]i response to 10
7
M BK (Figure 8b).
Note that the nonsignificant decrease observed in endo-
thelium-denuded AA after application of 5 107 M apelin
17, was usually followed by an [Ca2þ ]i enhancement of
23±6 nM (n¼ 5) (Figure 8b, inset). This suggests that these
[Ca2þ ]i increases observed in the absence of functional
endothelium could be mediated by apelin receptors located
on VSMC.
[Ca2þ ]i responses induced by apelin 17 in intact juxtamedul-
lary AA and muscular EA. This latter observation, that is,
[Ca2þ ]i increases induced by apelin 17 in the absence of
functional endothelium, led us to test whether apelin was
able to induce a [Ca2þ ]i increase when it was applied alone
both on AA and EA. Figure 9 shows that 5 107 M apelin 17
caused significant [Ca2þ ]i increases both in AA and in EA
with a significant higher amplitude in AA than in EA.
DISCUSSION
In rats, apelin receptor has a widespread pattern of express-
ion and is detected in several peripheral tissues with a
predominant vascular expression. Moderate but significant
levels of expression were detected in the kidney.5,20 In the
present study, we reported for the first time (i) the pattern of
distribution of apelin receptor mRNA in glomerular
arterioles and its quantification into the different renal zones
and along the rat nephron and (ii) the effects of apelin on
renal function and glomerular vasculature.
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Figure 7 | Effects of apelin 17 on [Ca2þ ]i responses to AngII
in juxtamedullary muscular efferent arterioles. (a) A
representative [Ca2þ ]i recording illustrating the [Ca
2þ ]i drops
produced when 5 107 M apelin 17 was added during the
plateau phase of the [Ca2þ ]i response induced by 10
9
M AngII
and when 108 M BK was added during the plateau phase of the
[Ca2þ ]i response induced by a second application of 10
9
M AngII.
(b) A representative [Ca2þ ]i recording illustrating the [Ca
2þ ]i
drops observed when 5 107 M apelin 17 was added during the
plateau phase of the [Ca2þ ]i responses induced by two successive
applications of 109 M AngII in the absence or presence of
2 105 M L-NAME. L-NAME was superfused 10 min before and
during the second application of AngII. (c) Summarized data
obtained in the absence and presence of L-NAME. Each column
represents the mean data±s.e.m. expressed in % of [Ca2þ ]i drop
induced by apelin 17 in the presence (hatched column, n¼ 10) or
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Figure 8 | Effects of arteriolar de-endothelialization on the
apelin 17-induced [Ca2þ ]i drop in juxtamedullary afferent
arterioles. (a) A representative [Ca2þ ]i recording type performed
on afferent arteriole with functional endothelium illustrating the
[Ca2þ ]i drop observed when 5 107 M apelin 17 was added
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[Ca2þ ]i increase followed by an application of 10
7
M BK, used in
so far as endothelium marker. The inset shows a representative
[Ca2þ ]i recording illustrating the [Ca
2þ ]i time course observed
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109 M AngII-induced [Ca2þ ]i increase in afferent arteriole without
functional endothelium. (c) Summarized data obtained in the
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We found the highest apelin receptor expression in the IS
consistent with the in situ hybridization data showing a
pronounced labeling of cells along the vasa recta in the same
region.20 In the OS and in the IM, a non-negligible apelin
receptor mRNA expression was detected and to a lesser extent
in the cortex. A high expression of apelin receptor mRNA was
found in glomeruli, about eightfold higher than in the
nephron segments where the expression was more moderate.
The apparent weak expression observed in the cortex can be
explained by the fact that the volume density of glomeruli is
lower compared to PCT that represented 76.4% in the
normal rat kidney cortex.31 The high expression of apelin
receptor mRNA in glomeruli was in good agreement with
data of O’Carroll et al.20 who found that labeling in the
kidney cortex corresponded to an apelin receptor mRNA
expression in B40% of glomeruli, suggesting a role for this
receptor in the regulation of blood flow or glomerular
filtration.
The expression of apelin receptor mRNA all along
the nephron suggested that apelin could modulate tubular
function. In a more interesting way, its presence in the
collecting duct, suggested that apelin might act as an
aquaretic peptide not only by a central action, as previously
showed,7,10,18 but also by an action on this segment known to
be the site of antidiuretic action of AVP through V2 receptors.
This hypothesis was supported by the fact that we presently
observed that intravenous injection of increasing doses of
apelin in lactating rats progressively increased diuresis, on
2-h analysis after the injection. This underlined the crucial
role played by apelin in the maintenance of body fluid
homeostasis and pointed out on the interest to develop non-
peptidic agonists of the apelin receptor. These compounds
could be an alternative approach to V2 receptor antagonists
for the treatment of water retention and hyponatremic
disorders.32
The diuretic action of apelin could also be mediated by
changes in renal hemodynamics. Indeed, a high expression of
apelin receptor mRNA within the glomeruli and the presence
of apelin-LI in VSMC and apelin receptor-LI both in VEC
and in VSMC of small intrarenal vessels were previously
reported22,23 and we showed here by in situ hybridization, the
presence of apelin receptor mRNA expression in the vascular
wall of glomerular arterioles, both in VEC and VSMC. This
led us to search for vasoactive effects of apelin in pre- and
post-glomerular arterioles that play a major role in the
regulation of glomerular hemodynamics. The juxtamedullary
area of the cortex was selected because medullary blood
circulation is almost exclusively supplied through juxtame-
dullary muscular EA that divide into several branches to form
descending vasa recta33 destined mostly for the IS, where we
observed the highest expression of apelin receptor mRNA.
Glomerular AA are exposed to high levels of AngII,34
leading to a need for a potent vasodilatator system that
can counteract AngII vasoconstriction. In the present study,
in AA and EA apelin caused a decrease in [Ca2þ ]i only
when [Ca2þ ]i was previously increased by AngII. These
data suggested a close link between apelin and AngII. We
demonstrated that the [Ca2þ ]i drop induced by apelin on the
plateau phase induced by AngII corresponded to an increase
in the diameter of the preconstricted AA, indicating that this
[Ca2þ ]i decrease was due to the change in vascular resistance.
The apelin-induced vasorelaxing effect observed in glome-
rular arterioles was in good agreement with its hypotensive
actions and the opposing actions for AngII and apelin on
blood pressure25 and vascular tone.26,35 AngII vasoconstric-
tion is modulated by vasoactive peptides such as BK in
glomerular arterioles.27 Comparison of apelin and BK effects
on [Ca2þ ]i responses to AngII indicated that the amplitude
and the duration of the [Ca2þ ]i drop was more important
for BK than for apelin, suggesting that BK was a more potent
relaxant hormone than apelin.
Inhibition of [Ca2þ ]i responses to AngII by apelin
was similar in juxtamedullary AA and EA. A difference of
sensitivity between AA and EA to vasoactive substances
such as AngII,36–38 adrenomedullin,39 and NO40 remains
controversial. In our study, the apelin-induced inhibition of
[Ca2þ ]i response to AngII in arterioles was abolished by
pretreatment of AA and EA with L-NAME, indicating that
apelin relaxed VSMC by releasing NO. In agreement with
these data, the hypotensive effect of apelin on blood pressure
was abolished in the presence of a NO synthase inhibitor in
rats24 and, apelin-induced phosphorylation of NO synthase
in lung VEC disappeared in APJ-deficient mice.25 To localize
in arterioles, the apelin receptors responsible for the [Ca2þ ]i
decrease, the effects of apelin were investigated on de-
endothelialized AA. In endothelium-denuded arterioles,
apelin failed to reduce the [Ca2þ ]i response to AngII, indi-
cating that the apelin receptors responsible for the [Ca2þ ]i
decrease in intact arterioles were located on the endo-
thelium layer. These data showed that apelin acted through
endothelial apelin receptors to release NO from endo-
thelium subsequently responsible for the [Ca2þ ]i decrease
in VSMC. In contrast to the inhibitory effect of apelin on
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Figure 9 | [Ca2þ ]i responses induced by 5 107 M apelin 17 in
juxtamedullary afferent and muscular efferent arterioles.
D[Ca2þ ]i is the magnitude of the response corresponding to the
difference between peak and basal concentrations. Each column
represents the mean data±s.e.m. calculated from five
determinations. **Po0.01.
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the AngII-induced [Ca2þ ]i response in intact arterioles, we
rather observed an increase in [Ca2þ ]i in de-endothelialized
arterioles. This supported the fact that the slight apelin-
induced [Ca2þ ]i increase observed in the absence of
functional endothelium originated from the action of
apelin on its receptor located on VSMC. This led us to
evaluate the effects of apelin alone on AA and EA. In these
conditions, apelin was able to induce rise in [Ca2þ ]i in both
arteriole types. This increase was higher in AA than in EA,
suggesting a higher sensitivity of AA to apelin regarding
vasoconstriction.
Overall, our results indicated that apelin was a peptide
involved both in vasorelaxation and vasoconstriction. Taking
into consideration, the high expression of apelin receptor
mRNA in the IS, a highly vascularized zone, and the
vasorelaxation induced by apelin in juxtamedullary AA and
muscular EA, our data are in agreement with a predominant
role for apelin rather in vasorelaxation than in vasoconstric-
tion as recently suggested by Kleinz and Davenport.41 The
AngII-induced vasoconstriction that was rapidly reversed
by apelin in AA and EA reinforced the opposing vascular
roles for the apelinergic and renin–angiotensin systems.
The apelin-dependent vasorelaxation that we observed in
muscular EA, which give rise to vasa recta, strongly suppor-
ted an important role for this peptide in the control of renal
medullary microcirculation. This potential apelin-induced
increase in medullary blood flow in addition to a direct
tubular effect might contribute to increase diuresis, as
observed in lactating rats. In contrast, AVP via V1a-R
decreases medullary blood flow by inducing vasoconstriction
of outer medullary descending vasa recta42 and decreases
urinary flow rate via V2-R. In our study, results bring
additional data for the opposite effects of apelin and AVP in
the maintenance of body fluid homeostasis not only at the
central7 but also at the peripheral level. Thus, apelin seems to
exert a complex and fine regulation on renal hemodynamic
functions through actions on pre- and post-glomerular
microvasculature and also probably on tubular functions.
MATERIALS AND METHODS
Animals
All procedures involving animals were carried out in accordance
with institutional guidelines for the care and use of laboratory
animals. Male Sprague–Dawley rats (130–180 g BW), virgin female
Sprague–Dawley rats (250–300 g BW), and lactating female
Sprague–Dawley rats (day 9 of lactation, 280–420 g BW) were used.
They were fed a normal standard diet and offered water ad libitum.
Measurement of diuresis rate
Experiments were performed on virgin or lactating female rats
under inactin anesthesia. The right jugular vein and bladder were
cannulated. For all animals, after a stabilizing period of 30 min, an
acute intravenous injection of saline (400 ml) was performed to
determine baseline values of diuresis rate (120 min basal period).
Then, virgin and lactating female rats received 400ml of either saline
or different doses of apelin (120 min experimental period). Diuresis
rate was expressed in microliter per minute per 100 g BW.
Isolation of renal zones
The kidneys of rats were cut into coronal slices and the different
renal zones, cortex, OS and IS of the outer medulla, and IM were
isolated. The transition between cortex and OS being irregular, only
the superficial cortex and the deep outer stripe were taken to avoid
tissue zone contamination.
Microdissection of nephron segments
The left kidney of male rats was prepared for microdissection of
nephron as previously described.43 Pieces of the following segments
were isolated under stereomicroscopic observation: Glom; proximal
convoluted tubule; straight part of the proximal tubule of the cortex;
thick ascending limb from the outer medulla and from the cortex;
collecting duct from the cortex, the outer and the inner medulla.
The AA and muscular EA were isolated with the Glom and identified
according to their morphology and localization in the inner renal
cortex as previously described by Helou et al.44
Measurement of the arteriolar diameter
For these experiments, afferent arterioles were microdissected
attached to the Glom. Sequential photographies were recorded on
the same arteriole with a digital camera (Coolpix 5400; Nikon) in
the basal condition, then 1 min after adding 109 M AngII and 1 min
after addition of 5 107 M apelin 17 on vasoconstricted arterioles.
Diameter of each arteriole under each experimental condition was
measured at three measurement sites (B20, 60, and 100 mm
upstream of the Glom) with Adobe Photoshop and the average
diameter was calculated. Calibration was made using a stage
micrometer.
Arteriolar de-endothelialization
Kidney was infused in situ with medium to clear it from blood, and
infused with a solution of 10 mM H2O2 for 2 min.
45 After
eliminating residual H2O2 by infusing 15 ml medium, kidney was
prepared for microdissection of arterioles.44 De-endothelialization
was confirmed by the absence of [Ca2þ ]i response to 10
7
M BK, a
well-established endothelial stimulator.46
Measurements of [Ca2þ ]i
[Ca2þ ]i was measured as previously described.
47 Glomerular
arterioles were loaded with 5 mM Fura-2 AM at room temperature
for 120 min. For fluorescence measurements, each arteriole was
continuously superfused at 371C with either medium or the
solutions to be tested. AngII, BK, and apelin 17 were used for these
experiments. For studies with No-nitro-L-arginine methyl ester
(L-NAME), arteriole was superfused at 371C for 10 min. The calcium
response was evaluated by determining the magnitude of the
response (D[Ca2þ ]i), corresponding to the difference between peak
and basal concentrations (in nanomoles).
Real-time reverse transcription-PCR
Approximately either 50 mg of tissue from each renal zone, 50 Glom
or 50 mm tubular length was used for total RNA extraction. Total
RNAs were extracted and purified with RNA Plus kit (Qbiogene
Europe, Illkirch, France). Total RNAs were reverse transcribed
using random hexamers and reverse transcriptase (Invitrogen,
Cergy-Pontoise, France). Negative controls were performed to assess
the presence of a possible genomic contamination. Real-time PCR
reactions were performed on ABI PRISM 7000 sequence detection
system using TaqMan Universal PCR Master Mix and Assays-on-
Demand expression probes (Applied Biosystems, apelin receptor
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assay ID: Rn00580252_s1, 18S assay ID: Hs99999901_s1). Analysis
of relative apelin receptor gene expression was performed using the
comparative Ct method.
48 Results were normalized with the data
obtained from the 18S rRNA internal control and expressed (1) for
renal zones as the relative value standardized with a reference RNA
issued from a pool of 400 Glom and (2) for the nephron segments as
the relative value from 2 mm tubule in percentage of the value from
2 Glom obtained in the same run.
Molecular histology
The in situ hybridization of apelin receptor mRNA was performed
according to Sibony et al.49 with specific antisense and sense cRNA
probes.9
Statistical analysis
All the results are mean values of replicate samples±s.e.m.
Statistical differences were assessed using Student’s unpaired t-test,
or one-way analysis of variance (ANOVA) on weighted means
followed by Fisher’s test.
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